LEXINGTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative ...

Shares fell more than 8% in premarket trading. The company said it was halting the development program in light of disappointing preclinical studies. Shares fell more than 8% in premarket trading. The ...

A US software designer plans to harness the brains of the world’s computer users to build a multilingual translation database. Brian McConnell believes it could provide a free way to translate the ...